Better Inputs, Better Outputs: High-Dimensional Data for Tomorrow’s RNA Medicines
-
Eclipsebio performs sequencing-based measurements of RNA biology, including measurements of secondary structure and translation
-
Their eVERSE portfolio supplies feature-rich, cell-specific RNA datasets that power smarter models for drug design
-
Their validation assays close the loop, creating a unified workflow from discovery to regulatory filing